Technology Networks: Could Regenerative Medicine Reverse Damage After a Heart Attack?
2026-07-02 · CellProthera · original cellprothera.com ↗
A cell therapy approach improved patients’ quality of life after a heartattack; plans for Phase 3 trials are underway. Technology Networks | Written by Izzy Hirst – Speaking with Matthieu de Kalbermatten – Edited by Anna MacDonald June 30, 2026 Read on line CellProthera and Alfresa Holdings sign a Memorandum of Understanding to Advance Phase 3 Development and Future wholesale distribution of ProtheraCytes® in Japan 11 August, 2026 Technology Networks: Could Regenerative Medicine Reverse Damage After a Heart Attack? 02 July, 2026 CellProthera Prepares For Phase 3 Push As Regenerative Cardiology Moves Closer To Clinical Reality 02 June, 2026
The release as fetched from its publisher. cellprothera.com ↗